IVVD CIK: 1832038

Invivyd, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
617
FY22:
377
FY23:
225
FY24:
101
FY25:
247
(positive)
Change from FY21 to FY25
millions USD
FY21:
3.38
FY22:
6.25
FY23:
4.30
FY24:
28.8
FY25:
29.4
Total assets
Change from FY21 to FY25
millions USD
FY21:
620
FY22:
383
FY23:
229
FY24:
130
FY25:
277

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
62.1
FY22:
25.0
FY23:
50.3
FY24:
62.0
FY25:
34.2
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.01
FY22:
2.17
FY23:
1.42
FY24:
0
FY25:
1.18
(positive)
Change from FY21 to FY25
millions USD
FY21:
558
FY22:
356
FY23:
177
FY24:
67.5
FY25:
242
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
620
FY22:
383
FY23:
229
FY24:
130
FY25:
277

All amounts in millions USD Data source:SEC EDGAR